<DOC>
	<DOCNO>NCT00858286</DOCNO>
	<brief_summary>The purpose study describe detail control lack control asthma , base two different dose strategy , regular treatment SERETIDE stable dose short act beta-2 agonist need , maintenance treatment SYMBICORT use inhaler SYMBICORT need .</brief_summary>
	<brief_title>A Follow-up Survey Compare Stable Dosing ( SERETIDE ) With SYMBICORT , SMART , Maintenance Reliever Therapy One Inhaler Moderate Severe Asthmatics .</brief_title>
	<detailed_description>The purpose study describe detail control lack control asthma , base two different dose strategy . No therapy intervention make exist prescribed medication ( SERETIDE SYMBICORT ) , evaluation outside standard care make evluations diary card , questionnaire , PEF evaluation spirometry regard intervention Swedish Authorities .</detailed_description>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>write informed consent 18 year able fill questionnaire perform PEF measurement asthma diagnosis prescribe SERETIDE SYMBICORT , either regular treatment use SERETIDE stable dose short act B2 agonist need , maintenance treatment SYMBICORT also use inhaler SYMBICORT need lung disease neurological disease psychological handicap cerebrovascular disease handicap unstable cancer know planned pregnancy time study subject serious uncontrolled disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>